Literature DB >> 12642780

Peroxisome proliferator-activated receptors beta/delta: emerging roles for a previously neglected third family member.

Liliane Michalik1, Béatrice Desvergne, Walter Wahli.   

Abstract

PURPOSE OF REVIEW: Peroxisome proliferator-activated receptors alpha, beta/delta and gamma are members of the nuclear receptor superfamily. They mediate the effects of fatty acids and their derivatives at the transcriptional level, and are considered to be lipid sensors that participate in the regulation of energy homeostasis. Compared with the alpha and gamma peroxisome proliferator-activated receptor isotypes, peroxisome proliferator-activated receptor beta functions have long remained an enigma. In this review, we focus on emerging knowledge about peroxisome proliferator-activated receptor beta activation and roles. RECENT
FINDINGS: We review recent data that suggest key roles in basic cell functions, such as proliferation, differentiation and survival, and in embryonic development and lipid metabolism in peripheral tissues.
SUMMARY: The newly unveiled roles of peroxisome proliferator-activated receptor beta in important basic cell functions certainly justify a further exploration of its potential as a therapeutic target in pathologies such as metabolic syndrome X or skin diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642780     DOI: 10.1097/00041433-200304000-00003

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  15 in total

Review 1.  Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis.

Authors:  Nicolas Di-Poï; Liliane Michalik; Béatrice Desvergne; Walter Wahli
Journal:  Lipids       Date:  2004-11       Impact factor: 1.880

2.  Peroxisome proliferator-activated receptor γ and colorectal cancer.

Authors:  Yun Dai; Wei-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

3.  Curcumin suppresses PPARdelta expression and related genes in HT-29 cells.

Authors:  Jin-Bo Wang; Li-Li Qi; Shui-Di Zheng; Heng-Zheng Wang; Tian-Xing Wu
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

4.  PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors.

Authors:  Elisabetta Benedetti; Renato Galzio; Barbara D'Angelo; Maria Paola Cerù; Annamaria Cimini
Journal:  PPAR Res       Date:  2010-03-17       Impact factor: 4.964

5.  Expression of epidermal fatty acid binding protein (E-FABP) in septoclasts in the growth plate cartilage of mice.

Authors:  Yasuhiko Bando; Miyuki Yamamoto; Koji Sakiyama; Katsuyuki Inoue; Shota Takizawa; Yuji Owada; Shoichi Iseki; Hisatake Kondo; Osamu Amano
Journal:  J Mol Histol       Date:  2014-05-31       Impact factor: 2.611

Review 6.  Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis.

Authors:  G William Rebeck
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs.

Authors:  Yuhong Yang; Amy E Lovett-Racke; Michael K Racke
Journal:  PPAR Res       Date:  2010-12-22       Impact factor: 4.964

8.  Role of PPARs in Radiation-Induced Brain Injury.

Authors:  Sriram Ramanan; Weiling Zhao; David R Riddle; Mike E Robbins
Journal:  PPAR Res       Date:  2009-09-17       Impact factor: 4.964

9.  Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins.

Authors:  Maria Vittoria Simonini; Paul E Polak; Anne I Boullerne; Jeffrey M Peters; Jill C Richardson; Douglas L Feinstein
Journal:  ASN Neuro       Date:  2010-01-15       Impact factor: 5.200

10.  Role of Peroxisome Proliferator-Activated Receptor β/δ and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells.

Authors:  Jeffrey D Coleman; Jerry T Thompson; Russell W Smith; Bogdan Prokopczyk; John P Vanden Heuvel
Journal:  PPAR Res       Date:  2013-05-02       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.